Argus Research Maintains Buy on Hologic, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Argus Research analyst David Toung maintains a Buy rating on Hologic (NASDAQ:HOLX) and raises the price target from $89 to $95, indicating a positive outlook on the stock.
May 09, 2024 | 3:43 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Argus Research maintains a Buy rating on Hologic and increases the price target to $95, suggesting confidence in the company's future performance.
The increase in price target by a reputable analyst firm like Argus Research typically signals a strong bullish outlook on the stock, likely leading to positive investor sentiment and potential short-term price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100